These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 19911371)
1. Nuclear redistribution of TCERG1 is required for its ability to inhibit the transcriptional and anti-proliferative activities of C/EBPalpha. Banman SL; McFie PJ; Wilson HL; Roesler WJ J Cell Biochem; 2010 Jan; 109(1):140-51. PubMed ID: 19911371 [TBL] [Abstract][Full Text] [Related]
2. TCERG1 inhibits C/EBPα through a mechanism that does not involve sequestration of C/EBPα at pericentromeric heterochromatin. Moazed B; Banman SL; Wilkinson GA; Roesler WJ J Cell Biochem; 2011 Sep; 112(9):2317-26. PubMed ID: 21503969 [TBL] [Abstract][Full Text] [Related]
3. The Glutamine-Alanine Repeat Domain of TCERG1 is Required for the Inhibition of the Growth Arrest Activity of C/EBPα. Miller NJ; Schick K; Timchenko N; Harrison E; Roesler WJ J Cell Biochem; 2016 Mar; 117(3):612-20. PubMed ID: 26264132 [TBL] [Abstract][Full Text] [Related]
4. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1. Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049 [TBL] [Abstract][Full Text] [Related]
5. CCAAT/enhancer-binding protein alpha antagonizes transcriptional activity of hypoxia-inducible factor 1 alpha with direct protein-protein interaction. Yang L; Jiang Y; Wu SF; Zhou MY; Wu YL; Chen GQ Carcinogenesis; 2008 Feb; 29(2):291-8. PubMed ID: 18024476 [TBL] [Abstract][Full Text] [Related]
6. The tumour necrosis factor-alpha-mediated suppression of the CCAAT/enhancer binding protein-alpha gene transcription in hepatocytes involves inhibition of autoregulation. Foka P; Singh NN; Salter RC; Ramji DP Int J Biochem Cell Biol; 2009 May; 41(5):1189-97. PubMed ID: 19027873 [TBL] [Abstract][Full Text] [Related]
7. C/EBPalpha activates the transcription of triacylglycerol hydrolase in 3T3-L1 adipocytes. Wei E; Lehner R; Vance DE Biochem J; 2005 Jun; 388(Pt 3):959-66. PubMed ID: 15752068 [TBL] [Abstract][Full Text] [Related]
8. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50. Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells. Liu YN; Kang BB; Chen JH Oncogene; 2004 Jan; 23(1):278-88. PubMed ID: 14712233 [TBL] [Abstract][Full Text] [Related]
10. Identification of a co-repressor that inhibits the transcriptional and growth-arrest activities of CCAAT/enhancer-binding protein alpha. McFie PJ; Wang GL; Timchenko NA; Wilson HL; Hu X; Roesler WJ J Biol Chem; 2006 Jun; 281(26):18069-80. PubMed ID: 16644732 [TBL] [Abstract][Full Text] [Related]
11. Role of C/EBP homologous protein (CHOP-10) in the programmed activation of CCAAT/enhancer-binding protein-beta during adipogenesis. Tang QQ; Lane MD Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12446-50. PubMed ID: 11050169 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional repression of the gluconeogenic gene PEPCK by the orphan nuclear receptor SHP through inhibitory interaction with C/EBPalpha. Park MJ; Kong HJ; Kim HY; Kim HH; Kim JH; Cheong JH Biochem J; 2007 Mar; 402(3):567-74. PubMed ID: 17094771 [TBL] [Abstract][Full Text] [Related]
13. Functional interaction of transcriptional coactivator ASC-2 and C/EBPalpha in granulocyte differentiation of HL-60 promyelocytic cell. Hong S; Lee MY; Cheong J Biochem Biophys Res Commun; 2001 Apr; 282(5):1257-62. PubMed ID: 11302752 [TBL] [Abstract][Full Text] [Related]
14. CCAAT/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma. Tan EH; Hooi SC; Laban M; Wong E; Ponniah S; Wee A; Wang ND Cancer Res; 2005 Nov; 65(22):10330-7. PubMed ID: 16288022 [TBL] [Abstract][Full Text] [Related]
16. Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPalpha by inhibiting its ubiquitination. Trivedi AK; Bararia D; Christopeit M; Peerzada AA; Singh SM; Kieser A; Hiddemann W; Behre HM; Behre G Oncogene; 2007 Mar; 26(12):1789-801. PubMed ID: 16983342 [TBL] [Abstract][Full Text] [Related]
17. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene. Asou H; Gombart AF; Takeuchi S; Tanaka H; Tanioka M; Matsui H; Kimura A; Inaba T; Koeffler HP Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245 [TBL] [Abstract][Full Text] [Related]
18. ATF4 differentially regulates transcriptional activation of myeloid-specific genes by C/EBPepsilon and C/EBPalpha. Gombart AF; Grewal J; Koeffler HP J Leukoc Biol; 2007 Jun; 81(6):1535-47. PubMed ID: 17347301 [TBL] [Abstract][Full Text] [Related]
19. p300 coactivates the adipogenic transcription factor CCAAT/enhancer-binding protein alpha. Erickson RL; Hemati N; Ross SE; MacDougald OA J Biol Chem; 2001 May; 276(19):16348-55. PubMed ID: 11340085 [TBL] [Abstract][Full Text] [Related]
20. Functional sequestration of transcription factor activity by repetitive DNA. Liu X; Wu B; Szary J; Kofoed EM; Schaufele F J Biol Chem; 2007 Jul; 282(29):20868-76. PubMed ID: 17526489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]